[SOURCE] Shinva Medical Instrument Co., Ltd. 2025 Annual Report: Revenue of 9.736 Billion Yuan, Medical Device Manufacturing Product Revenue of 3.695 Billion Yuan [SOURCE] DENTALGOODNEWS (Leading Den…

Source: Xinhua Medical 2025 Annual Report

DentalGoodNews｜On April 30, 2026, Shandong Shinva Medical Instrument Co., Ltd. (hereinafter referred to as "Shinva Medical") released its 2025 annual report. According to the report data, the company achieved operating revenue of RMB 9.736 billion in 2025, a year-on-year decrease of 2.84%; net profit attributable to shareholders of the listed company was RMB 526 million, a year-on-year decrease of 23.90%; net profit attributable to shareholders of the listed company excluding Non-recurring Gains and Losses was RMB 457 million, a year-on-year decrease of 26.66%.

Source: Xinhua Medical 2025 Annual Report

In 2025, the company achieved net profit attributable to shareholders of the listed company excluding Non-recurring Gains and Losses of RMB 457 million, a year-on-year decrease of 26.66%. The decline in profit was greater than the decline in revenue, mainly due to increased sales expenses and reduced interest income (leading to higher financial expenses). During the reporting period, the company's sales expenses were RMB 894 million, a year-on-year increase of 2.93%.

Source: Xinhua Medical 2025 Annual Report

In the core business segments, revenue from Medical Devices manufacturing products was RMB 3.695 billion, a year-on-year decrease of 1.08%, with a gross profit margin of 40.41%; the combined revenue share of Medical Devices manufacturing products and pharmaceutical equipment products in main business income increased to 63.69%, up 3.83 percentage points from 2024. Among them, as one of the nine major product lines, Oral equipment and Consumables launched new products such as intraoral scanners.

Source: Xinhua Medical 2025 Annual Report

The overseas market achieved rapid growth during the reporting period. The company's overseas (self-operated) revenue reached RMB 396 million, a year-on-year increase of 46.04%, with a gross profit margin of 42.53%. The company has established five overseas sales centers in countries including Germany, Egypt, and Indonesia, accelerating its global layout.

In terms of financial quality, net cash flow from operating activities was RMB 701 million, a year-on-year increase of 55.44%. According to reports from DENTALGOODNEWS (Leading Dental Industry Media, DGN), in the first three quarters of 2025, the company's net Operating Cash Flow (OCF) year-on-year increase had reached 707.49%.

Source: Xinhua Medical 2025 Annual Report

In terms of asset structure, the company completed the equity transfer or liquidation of three non-core subsidiaries, including Shandong Shinva Changguo Hospital Investment Management Co., Ltd., further concentrating resources on its core main business. During the reporting period, gains from the disposal of non-Current Assets were RMB 50.03 million.